Who owns Repare Therapeutics Ord?

Tip: Access positions for across all investors

Analyze quarterly positions in Repare Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Repare Therapeutics Ord stock

Who bought or sold Repare Therapeutics Ord this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 10M $75M 25% Dec 2023
 View chart
OrbiMed Advisors 3.3M $24M 0% Dec 2023
 View chart
Blue Owl Capital Holdings 3.1M $23M 100% Dec 2023
 View chart
ARK Investment Management 2.8M $21M 8% Dec 2023
 View chart
Versant Venture Management 2.6M $19M 0% Dec 2023
 View chart
Redmile Group 2.1M $16M -11% Dec 2023
 View chart
Artal Group 700k $5.1M 0% Dec 2023
 View chart
Aquilo Capital Management 633k $4.6M 100% Dec 2023
 View chart
Logos Global Management 600k $4.4M -25% Dec 2023
 View chart
Sumitomo Mitsui Trust Holdings 326k $2.4M 0% Dec 2023
 View chart
Nikko Asset Management Americas 326k $2.4M 0% Dec 2023
 View chart
Millennium Management 182k $1.3M 703% Dec 2023
 View chart
GSA Capital Partners 145k $1.1M 524% Dec 2023
 View chart
Bank Of Montreal 105k $817k -1% Dec 2023
 View chart
D. E. Shaw & Co 77k $563k 100% Dec 2023
 View chart
Citadel Advisors 72k $528k -49% Dec 2023
 View chart
Vanguard Group 63k $457k -17% Dec 2023
 View chart
Exchange Traded Concepts 55k $257k 302% Mar 2024
 View chart
Squarepoint Ops 55k $398k 200% Dec 2023
 View chart
Harbor Capital Advisors 48k $351k 14% Dec 2023
 View chart
Dimensional Fund Advisors 44k $322k -14% Dec 2023
 View chart
Jump Financial 40k $289k 100% Dec 2023
 View chart
Occudo Quantitative Strategies 31k $225k 100% Dec 2023
 View chart
Goldman Sachs Group 29k $211k -55% Dec 2023
 View chart
Jane Street 28k $208k 100% Dec 2023
 View chart
Corton Capital 28k $203k 100% Dec 2023
 View chart
Marshall Wace 27k $196k 100% Dec 2023
 View chart
Cubist Systematic Strategies 27k $195k 100% Dec 2023
 View chart
Blackstone Group 26k $190k 0% Dec 2023
 View chart
Two Sigma Investments 26k $186k 100% Dec 2023
 View chart
Bank of America Corporation 22k $158k 171% Dec 2023
 View chart
Connor, Clark & Lunn Investment Management 17k $122k 12% Dec 2023
 View chart
Brevan Howard Capital Management 16k $115k 100% Dec 2023
 View chart
Vontobel Holding 15k $110k 100% Dec 2023
 View chart
Compagnie Lombard, Odier SCA 14k $102k 0% Dec 2023
 View chart
Oracle Alpha 12k $90k 100% Dec 2023
 View chart
Simplex Trading 11k $77k -45% Dec 2023
 View chart
SRS Capital Advisors 10k $73k 100% Dec 2023
 View chart
Lazard Asset Management 3.0k $0 -70% Dec 2023
 View chart
National Bank Of Canada /fi/ 1.6k $12k -11% Dec 2023
 View chart
New York State Common Retirement Fund 1.3k $10k 0% Dec 2023
 View chart
TD Waterhouse Canada 1.3k $8.8k 0% Dec 2023
 View chart
Wells Fargo & Company 1.2k $8.6k -1% Dec 2023
 View chart
Royal Bank of Canada 1.0k $7.5k -26% Dec 2023
 View chart
Legal & General Group 706.00 $5.2k -94% Dec 2023
 View chart
Barclays 530.00 $4.0k -87% Dec 2023
 View chart
Citigroup 34.00 $247.999400 -94% Dec 2023
 View chart
UBS Group 7.00 $50.999900 -100% Dec 2023
 View chart
Jpmorgan Chase & Co 4.00 $29.000000 -100% Dec 2023
 View chart

Who sold out of Repare Therapeutics Ord?

Fund or Company Name Date Sold Shares Held Valued At
Caption Management Sep 2023 370k $4.5M
Point72 Asset Management Sep 2023 122k $1.5M
Swiss National Bank Sep 2023 41k $492k
Algert Coldiron Investors Sep 2023 31k $371k
Trexquant Investment Sep 2023 30k $356k
Credit Suisse Sep 2023 27k $326k
Hrt Financial Sep 2023 23k $275k
TD Asset Management Sep 2023 23k $275k
T. Rowe Price Associates Sep 2023 17k $206k
State of Wisconsin Investment Board Sep 2023 14k $165k
Raymond James Financial Services Advisors Sep 2023 12k $149k
China Universal Asset Management Sep 2023 1.1k $13k
Us Bancorp Sep 2023 533.00 $6.4k
Daiwa Securities Group Sep 2023 127.00 $2.0k